Taki Chemical Co., Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Dividend History 2Years Growth
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥75 | +36.4% |
| 2024 | ¥55 | +10.0% |
| 2023 | ¥50 | 0.0% |
| 2022 | ¥50 | 0.0% |
| 2021 | ¥50 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥35,846M | ¥34,852M | ¥38,916M | ¥41,977M |
| Gross Profit | ¥8,805M | ¥6,929M | ¥9,008M | ¥10,242M |
| Operating Income | ¥2,752M | ¥913M | ¥2,669M | ¥3,164M |
| Pretax Income | ¥3,050M | ¥1,967M | ¥3,274M | ¥4,390M |
| Net Income | ¥2,056M | ¥1,356M | ¥2,299M | ¥3,277M |
| EPS | ¥237.53 | ¥156.86 | ¥271.37 | ¥389.05 |
| Operating Margin | 7.68% | 2.62% | 6.86% | 7.54% |
| Balance Sheet | ||||
| Total Assets | ¥50,323M | ¥51,299M | ¥58,402M | ¥65,653M |
| Total Equity | ¥31,948M | ¥33,819M | ¥37,881M | ¥42,887M |
| Total Liabilities | ¥18,375M | ¥17,480M | ¥20,521M | ¥22,766M |
| Cash | ¥6,256M | ¥5,075M | ¥7,458M | ¥7,166M |
| Interest-bearing Debt | ¥1,237M | ¥1,145M | ¥1,216M | ¥1,265M |
| Equity Ratio | 63.49% | 65.93% | 64.86% | 65.32% |
| D/E Ratio | 0.04 | 0.03 | 0.03 | 0.03 |
| Cash Flow | ||||
| Operating CF | ¥1,444M | ¥1,620M | ¥4,343M | ¥2,310M |
| Investing CF | -¥1,083M | -¥1,640M | -¥1,613M | -¥1,056M |
| Financing CF | -¥543M | -¥1,169M | -¥352M | -¥1,455M |
| Free CF | ¥1,444M | ¥1,620M | ¥4,343M | ¥2,310M |
| Efficiency | ||||
| ROE | 6.44% | 4.01% | 6.07% | 7.64% |
| ROA | 4.09% | 2.64% | 3.94% | 4.99% |
Latest IR Information
-
Fiscal Year 2026 December Term, Q2 Interim Financial Summary [Japanese Standards] (Consolidated)
For the six months ended December 2026, consolidated net sales were 23,489,000,000, up 12.0% year over year; operating income was 2,257,000,000, up 32.6%; ordinary income was 2,624,000,000, up 30.6%; net income attributable to owners of the parent was 1,868,000,000, up...
Read more -
Notice Regarding Upward Revision of Earnings Forecast and Dividend Forecast (Increased Dividend)
Full-year consolidated earnings forecast for the 令和8 year (2026) is raised. Revenue is revised from 43,000 million yen to 45,300 million yen, net profit attributable to owners of parent from 2,650 million yen to 3,500 million yen. At the same...
Read more
Latest News (5 items)
Company Information
About
Taki Chemical Co., Ltd. engages in the chemicals, water treatment, and functional materials businesses in Japan. The company operates through Agriculture, Chemicals, Building Materials, Oil, Real estate, and Transportation segments. It provides water treatment chemicals, including polyaluminum chloride for drinking and industrial water treatment, urban sewage treatment, effluent treatment from civil engineering works, industrial wastewater treatment, coagulation in production process, and organic sludge filtration and dehydration. The company also offers functional chemical materials, such as water-soluble aluminum compounds, including takiceram, aluminum phosphate-based binders, and takibine; hydrated silica; and high-purity metal oxide consist of high-purity tantalum and niobium pentaoxide. In addition, it develops high-purity biodegradable polymers for medical applications; and colloidal materials that make use of the unique properties of nano-size particles for photocatalysts, ultraviolet absorbing agents, and electroconductive materials. The company serves customers in various fields, including agriculture, chemicals, functional materials, and biotechnology. The company was formerly known as Taki Fertilizer Manufacturing Co., Ltd. and changed its name to Taki Chemical Co., Ltd. in 1974. Taki Chemical Co., Ltd. was founded in 1885 and is headquartered in Kakogawa, Japan.